CEL-SCI
VA - ViennaBiotechnology
Focus: CEL-SCI is a public biotechnology company founded in 1983 focused on biologics development, primarily in oncology and immunotherapy. The company operates from Vienna, VA and maintains a lean pipeline of early-to-mid stage programs.
Profile data last refreshed 7h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About CEL-SCI
AI assessmentNot HiringNo open roles listed right now. Follow CEL-SCI to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from CEL-SCI's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Leukocyte Interleukin, Injection 200IU
CondylomaClinical Trials (1)
NCT02115919Safety Study of Multikine in the Treatment of Perianal Warts
Phase 1Help build intelligence for CEL-SCI
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.